Search results
Results from the WOW.Com Content Network
COVID-19 vaccination roll out in AIIMS, New Delhi, India on 16 January 2021. India began its vaccination programme on 16 January 2021, operating 3,006 vaccination centres on the onset. [23] Each vaccination centre will offer either Covishield or Covaxin, but not both. [24] 165,714 people were vaccinated on the first day of availability.
COVID-19 vaccination roll out in AIIMS, New Delhi, India on 16 January 2021. Vaccination in India includes the use of vaccines in Indian public health and the place of vaccines in Indian society, policy, and research.
On 15 April 2021, Delhi Chief Minister Arvind Kejriwal announced a weekend curfew along with tight restrictions on weekdays in order to curb the second wave of COVID-19 infections. On 17 April 2022, Delhi saw a rise in cases, but the positivity rate has relatively reduced from 5.33% to 4.21% [22]
If a person was born on January 1, 2020, and Immunization Act specifies vaccine against measles could be received from age 12 months to 24 months, vaccination shall be practiced between December 31, 2020, and December 31, 2021 (not between January 2021 and January 2022.) [33] [34] Some vaccinations are scheduled in line with the school year ...
iNCOVACC (codenamed BBV154) [1] is an intranasal COVID-19 vaccine candidate developed by Bharat Biotech, [2] [3] American company Precision Virologics [4] [5] and the Washington University School of Medicine in St Louis, Missouri, United States.
In May 2020, Indian Council of Medical Research's (ICMR's) National Institute of Virology approved and provided the virus strains for developing an Indian COVID-19 vaccine. [ 25 ] [ 26 ] In June 2020, the company received permission to conduct Phase I and Phase II human trials of a developmental COVID-19 vaccine codenamed BBV152 , from the ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
Those existing vaccines are based on the 2P spike, while NDV-HXP-S is further refined via the same process, resulting in a new spike called HexaPro; [10] the 2P spike contained two prolines compared with HexaPro's six. It is also more resistant to heat and chemicals than the original 2P spike; the vaccine can be stored at 2–8 °C. [11]